Applied Industrial Technologies Earnings Call Transcripts
Fiscal Year 2027
-
Fiscal Q1 organic sales rose 7.1%, EBITDA increased 9.6% and EPS grew 12.7% YoY, with margin expansion despite LIFO headwinds. FY EPS guidance rose to $11.70-$12.20; sales and margin outlooks were maintained amid positive order momentum and macro uncertainty.
Fiscal Year 2026
-
Record Q4 sales and earnings were driven by 10% organic growth, strong automation and fluid power demand, and robust margin expansion. Fiscal 2027 guidance anticipates continued growth, with raised intermediate targets and a strong balance sheet supporting ongoing M&A and investment.
-
Third quarter saw 6% organic sales growth, record EBITDA, and strong momentum across both segments. Guidance for fiscal 2026 was raised to the high end, with continued focus on M&A, share buybacks, and navigating macro and geopolitical uncertainties.
-
Q2 results met guidance with 2.2% organic sales growth and strong order momentum, especially in Engineered Solutions and automation. FY26 EPS guidance was raised, with higher LIFO expense and pricing contributions expected. Capital deployment remains robust, supported by strong cash flow and low leverage.
-
EBITDA and EPS grew 13% and 11% year-over-year, with strong service center performance and positive order momentum in engineered solutions. Full-year EPS guidance was raised, while sales and margin outlooks remain steady amid ongoing trade policy uncertainty.
Fiscal Year 2025
-
Record sales, EBITDA, and EPS were achieved in fiscal 2025, with strong cash generation and significant capital deployment. Fiscal 2026 guidance anticipates 4%-7% sales growth, margin expansion, and continued M&A activity, despite ongoing macro and trade policy uncertainty.
-
Gross margin, EBITDA, and EPS exceeded expectations in Q3, driven by cost controls and M&A, despite a 3% organic sales decline. Free cash flow hit record levels, supporting acquisitions and buybacks, while guidance reflects ongoing macro uncertainty and cautious customer spending.
-
Second quarter results showed margin and earnings growth despite a slight sales decline, supported by strong execution, cost controls, and the Hydradyne acquisition. Guidance for fiscal 2025 was raised, with continued focus on M&A, capital deployment, and operational enhancements.
-
Organic daily sales declined 3% year-over-year but exceeded expectations, with strong September trends and record free cash flow. Fiscal 2025 EPS guidance was raised, while sales and margin outlooks remain cautious amid mixed end market demand and macro uncertainty.
Fiscal Year 2024
-
Q4 saw double-digit earnings growth and record margins despite softer end market demand. FY25 guidance anticipates a slow first half with recovery in the second, supported by strong cash flow, active M&A, and ongoing investments.